| First Author | Sargent JK | Year | 2022 |
| Journal | Dis Model Mech | Volume | 15 |
| Issue | 9 | PubMed ID | 36037073 |
| Mgi Jnum | J:332675 | Mgi Id | MGI:7428533 |
| Doi | 10.1242/dmm.049457 | Citation | Sargent JK, et al. (2022) Genetically diverse mouse platform to xenograft cancer cells. Dis Model Mech 15(9) |
| abstractText | The lack of genetically diverse preclinical animal models in basic biology and efficacy testing has been cited as a potential cause of failure in clinical trials. We developed and characterized five diverse RAG1 null mouse strains as models that allow xenografts to grow. In these strains, we characterized the growth of breast cancer, leukemia and glioma cell lines. We found a wide range of growth characteristics that were far more dependent on strain than tumor type. For the breast cancer cell line, we characterized the spectrum of xenograft/tumor growth at structural, histological, cellular and molecular levels across each strain, and found that each strain captures unique structural components of the stroma. Furthermore, we showed that the increase in tumor-infiltrating myeloid CD45+ cells and the amount of circulating cytokine IL-6 and chemokine KC (also known as CXCL1) is associated with a higher tumor size in different strains. This resource is available to study established human xenografts, as well as difficult-to-xenograft tumors and growth of hematopoietic stems cells, and to decipher the role of myeloid cells in the development of spontaneous cancers. |
